Naropa’s Center for Psychedelic Studies (NCPS) will no longer be affiliated with the university, it announced Monday. The founding NCPS team is teaming up to launch the center with Boulder-based therapists and researchers who previously worked on Lykos Therapeutics and Multidisciplinary Association for Psychedelic Studies (MAPS) clinical trials for MDMA-assisted therapy. “So we may replace the psilocybin facilitator training program” with more focused, high-level programs, such as for end-of-life care or veterans with post-traumatic stress disorder (PTSD). The center’s foundational Certificate of Psychedelic-Assisted Therapies program (CPAT) will continue and will also meet the state’s requirements for psilocybin facilitator certification, he said: a 40-hour practicum in addition to 150 hours of instruction. The new center has inherited Naropa’s state license to offer psilocybin facilitator training, and is in the process of transferring the university’s Oregon certification.